PharmStars

Orbit Health is a health technology company that develops an artificial intelligence platform aimed at improving the management of chronic diseases, particularly Parkinson's disease. The platform offers continuous and objective insights into motor symptoms by utilizing smartwatch motion data, which is passively collected without disrupting patients' daily activities. This data allows physicians to tailor treatment plans, enabling patients to achieve optimal symptom control and enhance their quality of life. By focusing on the personalization of treatment, Orbit Health seeks to address the unique needs of individuals living with Parkinson's disease.

HealthQb is a company that focuses on remotely monitoring the biopsychosocial health of patients, particularly those with chronic illnesses. It provides a behavior modification system that utilizes wearables or smartwatches, accompanied by a patient application and healthcare portal. This technology enables healthcare providers, including physiotherapists and other practitioners, to access objective assessments of their patients' health. By doing so, they can guide patients towards achieving their health goals and addressing the root causes of unhealthy behaviors. HealthQb's approach aims to empower both patients and healthcare professionals in the management and improvement of health outcomes.

WKD.SMRT provides a platform that combines remote interaction with state-of-the-art digital technologies to deliver accurate and complete real-world data. They integrates data in the home with third party data and conventional clinical examinations.

Head Diagnostics is a life sciences technology company that specializes in the development of a non-invasive medical device designed to assess and evaluate brain impairment and disease. This innovative device allows for rapid assessment of concussions without the need for an initial baseline test, providing objective evaluations. By delivering real-time neuro data to hospitals, neurologists, physicians, and patients, Head Diagnostics aims to enhance patient outcomes and reduce reliance on traditional imaging methods such as CT scans.

Accexible focuses on the development of technology that extracts acoustic characteristics from the speech of a person who gives us clues to his health and well-being. Accexible identifies vocal biomarkers, specific characteristics of the voice that indicate various health conditions, for the diagnosis and monitoring of diseases

SmartTab is a pharmaceutical company that focuses on developing the Smart Drug Delivery and Monitoring Systems. Its platform technology is a wireless ingestible capsule containing an electronic receiver, smart polymer actuator, and active ingredients. The company is focused on the development of three drug delivery platforms, TargetTab™, InjectTab™ and MultiTab™. The company was founded in 2015 and headquartered in Denver, Colorado, United States.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, specializes in developing innovative solutions for the detection and management of neurocognitive and neuromotor disorders. The company has created neuroQWERTY, an artificial intelligence tool that passively collects data through everyday use of electronic devices, enabling 24/7 monitoring of disease progression and therapeutic effectiveness. This frictionless and non-invasive platform captures subtle changes in user interactions, such as typing and touchscreen behavior, which are often overlooked by traditional clinical assessments. With proven capabilities demonstrated in extensive clinical trials, nQ Medical aims to facilitate early detection of disorders like Alzheimer's, Parkinson's, and multiple sclerosis, while offering a cost-effective alternative to current diagnostic methods. By providing patients and clinicians with a reliable means to track disease status and treatment impact, nQ Medical is positioned to enhance the management of neurological conditions significantly.